Back
Soleno Therapeutics Vs. KalVista Pharmaceuticals Industry Stock Comparison
Buy
60
SLNO
Soleno Therapeutics
Last Price:
47.19
Seasonality Move:
42.76%
Buy
51
KALV
KalVista Pharmaceuticals
Last Price:
9.11
Seasonality Move:
13.48%
Buy
60
Soleno Therapeutics (SLNO)
is a Buy
Is Soleno Therapeutics a Buy, Sell or Hold?
- The current Soleno Therapeutics [SLNO] share price is $47.35. The Score for SLNO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- SLNO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
KalVista Pharmaceuticals (KALV)
is a Buy
Is KalVista Pharmaceuticals a Buy, Sell or Hold?
- The current KalVista Pharmaceuticals [KALV] share price is $9.44. The Score for KALV is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- KALV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SLNO Stock Price Chart
What is Soleno Therapeutics's stock price today?
-
The Soleno Therapeutics share price today is $47.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLNO is experiencing slight selling pressure.
KALV Stock Price Chart
What is KalVista Pharmaceuticals's stock price today?
-
The KalVista Pharmaceuticals share price today is $9.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KALV is experiencing slight buying pressure.
SLNO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.57 | Sell |
| Relative Strength Index (14 RSI): | 33.77 | Sell |
| Chaikin Money Flow: | -200556 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.41 - 57.29) | Sell |
| Bollinger Bands (100): | (47.52 - 54.64) | Sell |
KALV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.38 | Sell |
| Relative Strength Index (14 RSI): | 42.65 | Sell |
| Chaikin Money Flow: | 86108 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.28 - 10.78) | Sell |
| Bollinger Bands (100): | (10.14 - 13.18) | Sell |
SLNO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.83 | Sell |
| 20-day SMA: | 52.98 | Sell |
| 50-day SMA: | 53.46 | Sell |
| 200-day SMA: | 47.2 | Buy |
| 8-day EMA: | 49.94 | Sell |
| 20-day EMA: | 52.14 | Sell |
| 50-day EMA: | 52.61 | Sell |
| 200-day EMA: | 46.25 | Buy |
KALV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.65 | Sell |
| 20-day SMA: | 9.73 | Sell |
| 50-day SMA: | 10.83 | Sell |
| 200-day SMA: | 11.89 | Sell |
| 8-day EMA: | 9.58 | Sell |
| 20-day EMA: | 9.9 | Sell |
| 50-day EMA: | 10.56 | Sell |
| 200-day EMA: | 11.42 | Sell |
Soleno Therapeutics Earnings Growth & SLNO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
KalVista Pharmaceuticals Earnings Growth & KALV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.06 per share, an increase this year of $0.40 per share, and a decrease next year of $0.61 per share.
Soleno Therapeutics Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
KalVista Pharmaceuticals Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||